HOMEVULNERABILITIESCVE-2026-6340
MEDIUM

CVE-2026-6340

CWE-789Published: May 18, 2026· Updated: May 19, 2026

6.5
CVSS v3.1
EPSS:0.04%probability of exploitation in 30 daysPercentile:12.6th

Official Description

Mattermost versions 11.5.x <= 11.5.1, 10.11.x <= 10.11.13, 11.4.x <= 11.4.3 fail to validate 7zip archive structure before processing which allows an authenticated attacker to cause server memory exhaustion and denial of service via uploading a specially crafted 7zip file with excessive folder declarations.. Mattermost Advisory ID: MMSA-2026-00573

NVD Source

Technical Analysis

CVE-2026-6340 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

A successful exploit results in availability disruption (denial of service), with a CVSS base score of 6.5.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.Low
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityNone
IntegrityNone
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Affected Vendors & Products

mattermost1 product
mattermost server
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (1)

Quick Facts

CVE IDCVE-2026-6340
CVSS Score6.5 / 10
SeverityMEDIUM
WeaknessCWE-789
CISA KEVNo
EPSS (30d)0.04%
Affected1 vendor
PublishedMay 18, 2026

Related CVEs (CWE-789)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-6340 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.